At Riverain, we are relentless innovators that empower healthcare providers by streamlining diagnostic processes, elevating detection accuracy, and improving the outcomes of patients with cardiothoracic diagnoses. As imaging volume continues to grow along with the demand for faster turnaround times and earlier diagnoses, tools that improve efficiency and accuracy are essential. ClearRead™ Chest is a cardiothoracic AI suite that reduces reading time and eases cognitive burden while improving accuracy. A series of advanced AI algorithms are deployed and provide key insights and metrics on pulmonary nodules and CAC. Findings and analysis are then integrated in the radiology report.​ ClearRead is a valuable additional to lung cancer screening programs or for incidental nodule detection and CAC quantification.